Zogenix Inc. | Key People and Executives
Stephen J. Farr
President, Chief Executive Officer & Director
James B. Breitmeyer
Independent Director
Renee P. Tannenbaum
Independent Director
Louis C. Bock
Independent Director
Mark C. Wiggins
Independent Director
Erle T. Mast
Independent Director
Stephen J. Farr
President, Chief Executive Officer & Director
Michael Patrick Smith
CFO, Secretary, Treasurer & Executive VP
Bradley S. Galer
Chief Medical Officer & Executive Vice President
Ashish Sagrolikar
Chief Commercial Officer & Executive VP
Gail M. Farfel
Chief Development Officer & Executive VP
Steven A. Johnson
Vice President & Compliance Officer
Catherine O'Connor
Senior Director-Commercial Communications
Arnold R. Gammaitoni
Vice President-Medical & Scientific Affairs
Jeff D. Durflinger
VP-Technical Operations & Product Supply
Stephen H. Jenner
Vice President-Marketing
James B. Breitmeyer
Independent Director
Renee P. Tannenbaum
Independent Director
Louis C. Bock
Independent Director
Mark C. Wiggins
Independent Director
Erle T. Mast
Independent Director
| Address |
5959 Horton Street
Emeryville California 94608
United States
|
|
Employees
|
- |
| Website |
http://www.zogenix.com |
| Updated |
07/08/2019 |
| Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. |
